UNSPSC 51183507: Buformin hydrochloride

This classification denotes an anti-diabetic agent with the molecular formula C6H15N5.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D947SXO87P, chemically known as imidodicarbonimidic diamide, n-butyl- but more generally known as buformin hydrochloride, which bears US NIH Compound Identifier 2468. European Medicines Agency schedules Buformin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00892MIG.

Most nations, for tariff and trade purposes, schedule buformin hydrochloride under HS 29252900 and SITC 51482. As of Q4 2014, BUFORMIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Buformin hydrochloride bears US NLM identifiers UMLS ID C2987056 and NCI Concept Code C95329. SMILES: CCCCNC(=N)NC(=N)N.CL.

UNSPSC 51183507 Buformin hydrochloride is a Commodity code covering a specific pharmaceutical active ingredient used in diabetes management and metabolic disorder treatment. State and local governments procure this substance primarily through health departments, correctional health systems, and public hospital networks to support inmate and indigent patient care programs. The drug is typically acquired as a bulk chemical or finished pharmaceutical formulation through competitive bidding processes, often as part of larger pharmacy supply contracts or formulary management initiatives.

The source provides no recent state and local contract opportunities tagged to this code. Without posted solicitations or awarded contracts in the available record, the current procurement activity level and geographic distribution cannot be characterized.